Kuo, Y.-H.; Huang, T.-H.; Wang, J.-H.; Chen, Y.-Y.; Tsai, M.-C.; Chen, Y.-H.; Lu, S.-N.; Hu, T.-H.; Chen, C.-H.; Hung, C.-H.
Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib. Cancers 2022, 14, 3971.
https://doi.org/10.3390/cancers14163971
AMA Style
Kuo Y-H, Huang T-H, Wang J-H, Chen Y-Y, Tsai M-C, Chen Y-H, Lu S-N, Hu T-H, Chen C-H, Hung C-H.
Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib. Cancers. 2022; 14(16):3971.
https://doi.org/10.3390/cancers14163971
Chicago/Turabian Style
Kuo, Yuan-Hung, Tzu-Hsin Huang, Jing-Houng Wang, Yen-Yang Chen, Ming-Chao Tsai, Yen-Hao Chen, Sheng-Nan Lu, Tsung-Hui Hu, Chien-Hung Chen, and Chao-Hung Hung.
2022. "Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib" Cancers 14, no. 16: 3971.
https://doi.org/10.3390/cancers14163971
APA Style
Kuo, Y.-H., Huang, T.-H., Wang, J.-H., Chen, Y.-Y., Tsai, M.-C., Chen, Y.-H., Lu, S.-N., Hu, T.-H., Chen, C.-H., & Hung, C.-H.
(2022). Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib. Cancers, 14(16), 3971.
https://doi.org/10.3390/cancers14163971
